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Coexistence of parathyroid adenoma and papillary 
thyroid carcinoma
Yong Sang Lee, Kee-Hyun Nam, Woong Youn Chung, Hang-Seok Chang, Cheong Soo Park
Thyroid Cancer Center, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
Purpose: Although several reports have been published regarding the coexistence of hyperparathyroidism and papillary 
thyroid carcinomas, concurrence of parathyroid adenoma and papillary thyroid carcinoma is extremely rare. The aim of this 
study was to describe experiences with concurrent parathyroid adenoma and papillary thyroid carcinoma. Methods: Seven 
patients with concurrent parathyroid adenoma and papillary thyroid carcinoma were identified between January 2006 and 
December 2007, and their medical records were reviewed retrospectively. Results: Of the seven patients identified, three were 
male and four were female; their mean age was 53.6 years. None of the patients presented with symptomatic hyper-
parathyroidism preoperatively. On laboratory findings, four patients had mild to moderate hypercalcemia, but serum para-
thyroid hormone concentrations were high in all patients. Preoperative imaging showed suspicious features of diseased par-
athyroid glands in four patients; two upon ultrasonography and computed tomography together and two upon ultra-
sonography only. The coexistence of parathyroid adenoma did not affect the extent of thyroid surgery. Laboratory values af-
ter surgery returned to within normal ranges in all patients. Conclusion: It is important not only to analyze serum calcium 
levels but also to carefully interpret imaging studies in order to identify asymptomatic hyperparathyroidism when perform-
ing thyroid cancer surgery.
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INTRODUCTION
Primary hyperparathyroidism is present in up to 0.1% 
of the general population, and it is clinically recognized in 
patients presenting with hypercalcemia or as a part of 
multiple endocrine neoplasia (MEN) types I and IIa [1]. 
Although there have been sporadic reports of the coex-
istence of hyperparathyroidism and non-medullary thy-
roid carcinoma [2], concurrence of parathyroid adenoma 
and papillary thyroid carcinoma is extremely rare. In most 
reports discussing the coexistence of these two diseases, 
primary hyperparathyroidism was diagnosed before the 
identification of the thyroid carcinoma which was usually 
diagnosed in a pathology specimens [3,4]. Since the coex-
istence of both disease processes can complicate patient 
management via untreated hypercalcemia, unrecognized 
thyroid cancer, and the necessity of re-operative neck sur-
gery, patients should be screened for both disease entities 
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Table 1. Clinicopathologic features of patients
Sex/ Suspicious for Size of  Central 
Thyroidectomy Complications
age parathyroid disease PTC (cm) node
iPTH Calcium Phosphorus 
  
(pg/mL) (mg/dL) (mg/dL)
Preop Postop Preop Postop Preop Postop
F/50 No 0.8 ＋ Total Hypocalcemia 56.86 1.48 10.6 9.5 3.3 3.2
F/50 US, CT 0.5 ＋ Total None 159.51 28.49 15.0 9.3 2.5 4.7
F/64 US, CT 0.8 － Less-than-total None 156.54 6.4 13.0 8.5 2.7 3.1
M/67 No 2.7 － Total None 57.44 5.01 9.7 8.5 3.1 3.8
F/44 US 1.5 － Total Hypocalcemia 73.45 5.26 11.8 10.1 3.5 3.7
M/27 US 0.6 ＋ Total Hypocalcemia 100.78 15.52 9.4 8.5 4.6 2.3
M/73 No 0.2 ＋ Total Seroma 101.74 3.25 9.6 8.5 3.1 4.1
US, ultrasonography; CT, computed tomography; PTC, papillary thyroid carcinoma; iPTH, intact parathyroid hormone; Preop, preoperation;
Postop, postoperation.
carefully.
The aim of this study was to describe our experiences 
with concurrent parathyroid adenoma and papillary thy-
roid carcinoma in a same patient.
METHODS
Of the 3,137 patients who underwent thyroid cancer 
surgery at the Thyroid Cancer Center, Department of 
Surgery, Yonsei University College of Medicine between 
January 2006 and December 2007, seven patients (0.2%) 
who had concurrent parathyroid adenoma and papillary 
thyroid carcinoma. Information regarding patient demo-
graphics, biochemical concentrations, tumor pathologic 
findings, extent of surgery, and postoperative complica-
tions was extracted from the medical records and re-
viewed retrospectively. Written informed consents of each 
patient were obtained from the each patient for pub-
lication of this article.
RESULTS
The clinicopathologic characteristics of the patients are 
listed in Table 1. Of the seven patients, 3 (42.9%) were male 
and 4 (57.1%) were female. The mean age of the patients 
was 53.6 years (range, 27 to 73 years). None of patients had 
a history of head and neck irradiation or prior neck 
surgery. One patient had a history of hyperthyroidism, 
and two patients had histories of hypertension treated 
with anti-hypertensive agents. 
All patients presented with thyroid nodules detected by 
medical check-ups and none of the seven patients were ini-
tially seen for symptomatic hypercalcemia. On pre-
operative laboratory findings, four patients had mild to 
moderate hypercalcemia, while the others had normal se-
rum calcium concentrations. The mean serum calcium 
concentration was 11.4 mg/dL (range, 9.6 to 15.0 mg/dL). 
All seven patients had normal serum phosphorus concen-
trations with a mean concentration of 3.2 mg/dL (range, 
2.5 to 4.5 mg/dL). Intact parathyroid hormone (iPTH) con-
centrations were high in all patients, with a mean concen-
tration of 100.90 pg/mL (range, 57.44 to 159.51 pg/mL). 
Laboratory values after surgery were within normal 
ranges in all patients: 9.0 mg/dL (range, 8.5 to 10.1 mg/dL) 
for calcium concentrations: 3.5 mg/dL (range, 2.3 to 4.5 
mg/dL) for phosphorus concentrations; and 9.34 pg/mL 
(range, 1.48 to 28.49 pg/mL) for iPTH concentration (Fig. 
1).
During the preoperative evaluations for thyroid dis-
ease, neck ultrasonography and computed tomography 
scans were performed on all patients. Four patients were 
suspected to have diseased parathyroid glands; two were 
detected by ultrasonography and computed tomography 
and two by ultrasonography only. 
A total thyroidectomy was performed in six patients 
with thyroid carcinomas and a less-than-total thyroi-
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Fig. 2. Left hemithyroidectomy and left superior parathyroid 
adenoma (white arrow) specimen.
dectomy was performed in one patient (Fig. 2). Central 
node dissection was performed in all patients, and lateral 
neck dissection was not performed in any of patients. The 
coexistence of parathyroid adenoma did not affect the ex-
tent of thyroid surgery.
The mean size of the thyroid carcinoma was 1.01 cm 
(range, 0.2 to 2.7 cm), and four cases showed metastatic 
lymph nodes in the central compartment.
In regard to complications, postoperative transient hy-
pocalcemia occurred in three patients, and the symptoms 
were relieved within three months. Except for the devel-
opment of seroma in one patient, no other complications 
occurred.
DISCUSSION
Since synchronous thyroid and parathyroid disease 
was first described in 1947 [5], the incidence of thyroid dis-
ease in patients undergoing parathyroidectomy has been 
reported to be from 2.5 to 17.6%. Conversely, the frequency 
Fig. 1. Preoperative (preop) and postoperative (postop) laboratory 
values changes. 
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of primary hyperparathyroidism in patients with thyroid 
disease has been reported to range from 0.3 to 8.7% [2]. 
The frequency of coexistence of primary hyper-
parathyroidism and thyroid carcinoma is not well-known; 
only two studies have been conducted and have reported 
frequencies of 3.7% and 8.0% [3,4]. In the present study, 
primary hyperparathyroidism was diagnosed prior to the 
thyroid carcinomas, and the thyroid carcinomas were di-
agnosed from pathology specimens [3,4]. 
In the present series, primary hyperparathyroidism was 
0.2% of the patients with thyroid carcinoma. As different 
from the previous studies, the thyroid carcinoma was di-
agnosed prior to the diagnosis of primary hyper-
parathyroidism, and primary hyperparathyroidism was 
postoperatively diagnosed in the pathology specimens. To 
our knowledge, there is only one similar case report [6]. 
The pathogenesis of primary hyperparathyroidism and 
thyroid carcinoma coexistence has not been established. 
The oncogenic effect of hypercalcemia on the thyroid 
gland has been assumed [7], and low-dose radiation ther-
apy for the head and neck, especially in childhood and 
adolescence, is known to induce thyroid and parathyroid 
tumors [8,9]. In the present series, however, none of the pa-
tients showed severe hypercalcemia, and only four pa-
tients had mild to moderate clinically diagnosed 
hypercalcemia. Thus, the oncogenic effect of hyper-
calcemia was not applicable in the present series. No pa-
tients had a history of prior neck irradiation.
The occasional coexistence of papillary thyroid carcino-
ma and primary hyperparathyroidism may result in a dis-
crepancy between the clinical impression and the fine nee-
dle aspiration (FNA) cytology diagnosis, leading to the 
possibility of a false-positive FNA cytology diagnosis [10]. 
The final diagnosis of concurrent parathyroid adenoma 
and thyroid carcinoma can be established on post-
operative histopathologic examinations [11]. In the pres-
ent series, four patients were suspicious for coexisting par-
athyroid disease, and the confirmations of these con-
currences were made using the final histopathologic 
results. Coexistence of parathyroid disease had no influ-
ence on the surgical extent of thyroid cancer, and thyroid 
surgeries in our series were performed based on the inter-
national guidelines in our series [12]. Additional re-
sections for the diseased parathyroid glands were 
performed.
In conclusion, although concurrent parathyroid ad-
enoma and thyroid carcinoma is rare, they can and do 
coexist. Preoperative biochemical studies, including se-
rum calcium and iPTH concentrations, may be helpful to 
evaluate for occult primary hyperparathyroidism, and ap-
propriate treatment for the parathyroid pathology includ-
ing surgical resection should be performed for the pre-
vention of the adverse disease resulted from the untreated 
parathyroid disease post-thyroidectomy period. Further-
more, when a patient with thyroid cancer is diagnosed, a 
routine checkup for serum calcium is mandated after the 
removal of concomitant parathyroid lesion and iPTH is 
considered as useful method to confirm and screen the 
hypercalcemia. 
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